10x Genomics to Participate in Upcoming June Investor Conferences

NEXT STORY
PDS Biotech to Host Company Conference Call Following Oral Presentation of PDS0101 Data at 2021 ASCO Annual Meeting
PREV STORY
BeyondSpring Presents Phase 1 Data on the Anti-Cancer Effect of Plinabulin in Combination with Checkpoint Inhibitors in SCLC at the American Society of Clinical Oncology (ASCO) Annual Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Highly Anticipated Multiple Sclerosis Medicine Offers New Hope

MISSION, KS--(Marketwired - Apr 10, 2017) -  (Family Features) Multiple sclerosis (MS) is a ...

author_avatar
NASDAQ Market News

Immune Design Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update

-   New positive clinical and translational data for both lead agents -   Strong balance ...

author_avatar
NASDAQ Market News

Argos Reports Third Quarter 2017 Financial Results and Operational Highlights

DURHAM, N.C., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (NASDAQ:ARGS), an immuno-oncology ...

author_avatar
NASDAQ Market News